S&P 500 Futures
(0.26%) 5 309.25 points
Dow Jones Futures
(0.24%) 38 883 points
Nasdaq Futures
(0.39%) 18 663 points
Oil
(-0.22%) $76.82
Gas
(4.02%) $2.69
Gold
(-0.26%) $2 339.70
Silver
(-0.54%) $30.28
Platinum
(-0.20%) $1 039.90
USD/EUR
(0.01%) $0.921
USD/NOK
(-0.03%) $10.48
USD/GBP
(0.03%) $0.785
USD/RUB
(-0.33%) $90.13

Realtime updates for Cybin Inc. [CYBN]

Exchange: AMEX Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 16:00

0.11% $ 0.350

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation...

Stats
Today's Volume 1.57M
Average Volume 5.07M
Market Cap 265.89M
EPS $0 ( 2024-02-13 )
Next earnings date ( $-0.0300 ) 2024-06-25
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.590
ATR14 $0.00100 (0.29%)

Volume Correlation

Long: -0.15 (neutral)
Short: 0.68 (moderate)
Signal:(55.314) Neutral

Cybin Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cybin Inc. Correlation - Currency/Commodity

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Cybin Inc. Financials

Annual 2022
Revenue: $0
Gross Profit: $-251 000 (0.00 %)
EPS: $-0.220
FY 2022
Revenue: $0
Gross Profit: $-251 000 (0.00 %)
EPS: $-0.220
FY 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.430
FY 2021
Revenue: $864 000
Gross Profit: $200 000 (23.15 %)
EPS: $-0.320

Financial Reports:

No articles found.

Cybin Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Cybin Inc.

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.1602070331573 seconds
Number of API calls: 2
Number of DB calls: 8